Perioperative Hemostasis Management in Liver Transplantation
Conditions: Liver Transplant; Complications Sponsors: Soci été Française d ' Anesth ésie et de Réanimation; Laboratoire français de Fractionnement et de Biotechnologies Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 14, 2024 Category: Research Source Type: clinical trials
Phase 1 Study for IPG11406 in Health Volunteer
Conditions: Inflammatory Bowel Diseases Interventions: Drug: IPG11406 Sponsors: Nanjing Immunophage Biotech Co., Ltd; Zhejiang Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 13, 2024 Category: Research Source Type: clinical trials
Summary Toggle Krystal Biotech Receives FDA Fast Track Designation for Inhaled Oncology Candidate KB707 to Treat Solid Tumors of the Lung
PITTSBURGH, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the“Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - February 13, 2024 Category: Pharmaceuticals Source Type: clinical trials
Effectiveness and Safety of Collagen Membrane (FormaAid ®) in the Treatment of Periodontal Regeneration
Conditions: Guided Tissue Regeneration; Collagen Membrane; Dental Diseases Interventions: Device: FormaAid; Device: Bio-Gide Sponsors: Maxigen Biotech Inc.; Tri-Service General Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 12, 2024 Category: Research Source Type: clinical trials
A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Placebo in T2DM Patients
Conditions: Type 2 Diabetes Mellitus Interventions: Drug: Exendin-4 Fc fusion protein injection; Drug: Exendin-4 Fc fusion protein injection; Drug: Placebo Sponsors: Beijing Dongfang Biotech Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 12, 2024 Category: Research Source Type: clinical trials
A Study of RAY1225 in Participants With Obesity
Conditions: Obesity Interventions: Drug: RAY1225; Drug: Placebo Sponsors: Guangdong Raynovent Biotech Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 12, 2024 Category: Research Source Type: clinical trials
Safety and Efficacy Study for DC Vaccine in Recurrent or Progressive High-grade Gliomas
Conditions: WHO Grade III Gliomas; WHO Grade IV Gliomas Interventions: Biological: personalized dendritic cell injection ZSNeo-DC1.1 Sponsors: Beijing Tiantan Hospital; ZhongSheng BioTech Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 12, 2024 Category: Research Source Type: clinical trials
A Study of RAY1225 in Participants With Type 2 Diabetes
Conditions: T2DM (Type 2 Diabetes Mellitus) Interventions: Drug: RAY1225; Drug: Placebo Sponsors: Guangdong Raynovent Biotech Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 12, 2024 Category: Research Source Type: clinical trials
Glofitamab With Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma
Conditions: Mantle Cell Lymphoma Interventions: Biological: Obinutuzumab; Biological: Glofitamab; Drug: Pirtobrutinib; Procedure: Tumor Imaging; Procedure: Biospecimen Collection; Device: ClonoSeq Assay; Procedure: Bone Marrow Biopsy Sponsors: C. Babis Andreadis; Eli Lilly and Company; Genentech, Inc.; Adaptive Biotechnologies Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 12, 2024 Category: Research Source Type: clinical trials
Active Case Finding of Clinical Hand Foot Mouth Disease in Children Aged 6 Months Old to 18 Years Old in Indonesia
Conditions: Hand, Foot and Mouth Disease Interventions: Diagnostic Test: PCR Sponsors: Sinovac Biotech Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 9, 2024 Category: Research Source Type: clinical trials
Clinical Study on the Safety and Efficacy of QY-1-T in the Treatment of HBV-associated Advanced Liver Cancer
Conditions: Liver Cancer Interventions: Drug: QY-1-T Sponsors: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine; Zhongke Qiyuan (Shenzhen) Biotechnology Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 9, 2024 Category: Research Source Type: clinical trials
An Open-Label Study to Assess the Safety & Efficacy of Leniolisib in Japanese Patients With APDS
Conditions: APDS Gene Mutation Interventions: Drug: Leniolisib Sponsors: Pharming Technologies B.V.; Laboratory Corporation of America; Axial Biotech, Inc; CMIC Co, Ltd. Japan Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2024 Category: Research Source Type: clinical trials
Pharmacokinetics of ZSP1273 in Participants With Severe Kidney Disease
Conditions: Kidney Impairment Interventions: Drug: ZSP1273 Sponsors: Guangdong Raynovent Biotech Co., Ltd Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2024 Category: Research Source Type: clinical trials
Influence of JY09 on Pharmacokinetics of Metformin , Rosuvastatin , and Digoxin and the QT Interval Study in Overweight Chinese Subjects
Conditions: Diabetes Mellitus, Type 2; Overweight Interventions: Drug: Exendin-4 Fc fusion protein (JY09) injection; Drug: Metformin Hydrochloride tablet; Drug: Rosuvastatin calcium tablets; Drug: Digoxin tablet Sponsors: Beijing Dongfang Biotech Co., Ltd. Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2024 Category: Research Source Type: clinical trials
A Trial to Evaluate the Safety and Preliminary Efficacy of iNK in the Treatment of Subjects With Solid Tumor
Conditions: Solid Tumor Interventions: Biological: iNK Injection Sponsors: Nuwacell Biotechnologies Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2024 Category: Research Source Type: clinical trials
